Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shi-Dong Lu

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 18, 2016
Combination of 5-fluorouracil and 2-morphilino-8-phenyl-4H-chromen-4-one may inhibit liver cancer stem cell activityYu-Chong Peng, Shi-Dong Lu, Jian-Hong Zhong, et al.
Expert Review of Gastroenterology & Hepatology|October 26, 2019
Updates and advancements in the management of hepatocellular carcinoma patients after hepatectomyShi-Dong Lu, Lin Li, Xin-Min Liang, et al.
Oncotarget|January 26, 2017
Effects of antiviral therapy on post-hepatectomy HBV reactivation and liver function in HBV DNA-negative patients with HBV-related hepatocellular carcinomaWen-Feng Gong, Jian-Hong Zhong, Shi-Dong Lu, et al.
Medicine|September 4, 2015
Historical Comparison of Overall Survival after Hepatic Resection for Patients With Large and/or Multinodular Hepatocellular CarcinomaJian-Hong Zhong, Xue-Mei You, Shi-Dong Lu, et al.
Medicine|February 5, 2016
Preoperative Ratio of Neutrophils to Lymphocytes Predicts Postresection Survival in Selected Patients With Early or Intermediate Stage Hepatocellular CarcinomaShi-Dong Lu, Yan-Yan Wang, Ning-Fu Peng, et al.
Scientific Reports|February 10, 2017
High expression of AKR1B10 predicts low risk of early tumor recurrence in patients with hepatitis B virus-related hepatocellular carcinomaYan-Yan Wang, Lu-Nan Qi, Jian-Hong Zhong, et al.
Plos One|October 1, 2014
Hepatic resection is safe and effective for patients with hepatocellular carcinoma and portal hypertensionJian-Hong Zhong, Hang Li, Nan Xiao, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 18, 2016
Combination of 5-fluorouracil and 2-morphilino-8-phenyl-4H-chromen-4-one may inhibit liver cancer stem cell activityYu-Chong Peng, Shi-Dong Lu, Jian-Hong Zhong, et al.
Expert Review of Gastroenterology & Hepatology|October 26, 2019
Updates and advancements in the management of hepatocellular carcinoma patients after hepatectomyShi-Dong Lu, Lin Li, Xin-Min Liang, et al.
Oncotarget|January 26, 2017
Effects of antiviral therapy on post-hepatectomy HBV reactivation and liver function in HBV DNA-negative patients with HBV-related hepatocellular carcinomaWen-Feng Gong, Jian-Hong Zhong, Shi-Dong Lu, et al.
Medicine|September 4, 2015
Historical Comparison of Overall Survival after Hepatic Resection for Patients With Large and/or Multinodular Hepatocellular CarcinomaJian-Hong Zhong, Xue-Mei You, Shi-Dong Lu, et al.
Medicine|February 5, 2016
Preoperative Ratio of Neutrophils to Lymphocytes Predicts Postresection Survival in Selected Patients With Early or Intermediate Stage Hepatocellular CarcinomaShi-Dong Lu, Yan-Yan Wang, Ning-Fu Peng, et al.
Scientific Reports|February 10, 2017
High expression of AKR1B10 predicts low risk of early tumor recurrence in patients with hepatitis B virus-related hepatocellular carcinomaYan-Yan Wang, Lu-Nan Qi, Jian-Hong Zhong, et al.
Plos One|October 1, 2014
Hepatic resection is safe and effective for patients with hepatocellular carcinoma and portal hypertensionJian-Hong Zhong, Hang Li, Nan Xiao, et al.
Pageof 1